Teladoc Health Q3 2026 revenue dips 3%, net loss narrows, adjusted EBITDA rises 14%.

Teladoc Health reported a 3% decline in Q3 2026 revenue to $605.1 million, with a net loss of $26.9 million, improved from the prior year's $49.5 million loss. Adjusted EBITDA increased 14% to $79.4 million, driven by growth in the Integrated Care segment despite a 13% revenue drop in BetterHelp. The company is advancing virtual care innovations and expects full-year 2026 revenue between $2.395 and $2.441 billion, with adjusted EBITDA of $277 to $303 million. Focus remains on expanding insurance-covered services and AI-enabled solutions to strengthen future growth.

Teladoc Health's market cap stands at $1.17 billion as of Oct 29, 2026, 03:21 WIB, with a trading volume of nearly 4 million shares on Pluang. The stock price rose sharply by 17.05% in one day, reaching USD 7.55, reflecting increased investor interest despite the company's recent net loss. Enterprise value is $1.43 billion, indicating market valuation beyond equity alone.